Liquid Dayquil recalled due to insanitary conditions in distribution center
Liquid Dayquil (12/8oz) is being recalled by Gold Star Distribution due to insanitary conditions and rodent exposure in their distribution center. The recall affects all lots distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves manufacturing and storage deviations (rodent exposure in distribution center) with potential for contamination. No illnesses or injuries have been reported. Per the rubric, this qualifies as 'risk-of-harm products where injury has not yet been reported,' scoring 3 (High).
Plain-English summary
Liquid Dayquil (12/8oz) is being recalled by Gold Star Distribution Inc. due to insanitary conditions discovered in their distribution center. The FDA classified this as a Class II recall, which indicates a reasonable probability that the product could cause serious adverse health consequences.
The specific contamination risk involves rodent exposure and activity detected in the distribution facility. The conditions found constitute CGMP (Current Good Manufacturing Practice) deviations, which are manufacturing and storage standard violations.
All lots of Liquid Dayquil (12/8oz) that were distributed nationwide by Gold Star Distribution are included in this recall.
The recalled product
- Product
- LIQUID DAYQUIL 12/8oz
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug
- Hazard
- rodent-exposure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27